UBS Group’s Core Scientific Inc Tranche 1 Warrants CORZW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.35M Sell
154,450
-289
-0.2% -$3.1K ﹤0.01% 5307
2025
Q4
$1.31M Buy
154,739
+505
+0.3% +$5.6K ﹤0.01% 5348
2025
Q3
$1.79M Sell
154,234
-1,251
-0.8% -$10.6K ﹤0.01% 5056
2025
Q2
$1.69M Buy
155,485
+149,260
+2,398% +$742K ﹤0.01% 4983
2025
Q1
$18.9K Buy
6,225
+3,942
+173% +$24.2K ﹤0.01% 8274
2024
Q4
$18.8K Buy
+2,283
New +$20.6K ﹤0.01% 7919
2024
Q3
Sell
-24,103
Closed -$109K 9563
2024
Q2
$109K Buy
24,103
+18,923
+365% +$38.5K ﹤0.01% 6115
2024
Q1
$6.89K Buy
+5,180
New +$7.69K ﹤0.01% 7429

Other funds holding CORZW

UBS Group's CORZW Position: Q1 2026 in Review

UBS Group reduced its Core Scientific Inc Tranche 1 Warrants (CORZW) stake by 0.19% in Q1 2026, selling an estimated $3.1K and leaving 154,450 shares worth $1.35M. The position accounts for ﹤0.01% of the portfolio, ranked #5307.

UBS Group first reported a position in CORZW in Q1 2024 and has held it in 8 quarters since. The position peaked at $1.79M in Q3 2025. 63 funds tracked by Wall St. Rank hold CORZW as of Q1 2026.

  • UBS Group held 154,450 shares of Core Scientific Inc Tranche 1 Warrants worth $1.35M as of Q1 2026.
  • UBS Group sold 289 Core Scientific Inc Tranche 1 Warrants shares in Q1 2026, an estimated $3.1K.
  • Core Scientific Inc Tranche 1 Warrants made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #5307 holding.
  • UBS Group first reported a position in Core Scientific Inc Tranche 1 Warrants in Q1 2024 and has held it in 8 quarters since.
  • UBS Group's Core Scientific Inc Tranche 1 Warrants position peaked at $1.79M in Q3 2025.
  • 63 funds tracked by Wall St. Rank held Core Scientific Inc Tranche 1 Warrants as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.